Functional Control of Myosin Motors in the Cardiac Cycle

Overview

Journal Nat Rev Cardiol

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 19

PMID 39030271

Authors

Malcolm Irving

Affiliations

Soon will be listed here.

Abstract

Contraction of the heart is driven by cyclical interactions between myosin and actin filaments powered by ATP hydrolysis. The modular structure of heart muscle and the organ-level synchrony of the heartbeat ensure tight reciprocal coupling between this myosin ATPase cycle and the macroscopic cardiac cycle. The myosin motors respond to the cyclical activation of the actin and myosin filaments to drive the pressure changes that control the inflow and outflow valves of the heart chambers. Opening and closing of the valves in turn switches the myosin motors between roughly isometric and roughly isotonic contraction modes. Peak filament stress in the heart is much smaller than in fully activated skeletal muscle, although the myosin filaments in the two muscle types have the same number of myosin motors. Calculations indicate that only ~5% of the myosin motors in the heart are needed to generate peak systolic pressure, although many more motors are needed to drive ejection. Tight regulation of the number of active motors is essential for the efficient functioning of the healthy heart - this control is commonly disrupted by gene variants associated with inherited heart disease, and its restoration might be a useful end point in the development of novel therapies.

Citing Articles

Mavacamten inhibits myosin activity by stabilising the myosin interacting-heads motif and stalling motor force generation.

McMillan S, Pitts J, Barua B, Winkelmann D, Scarff C bioRxiv. 2025; .

PMID: 39990378 PMC: 11844505. DOI: 10.1101/2025.02.12.637875.

The Mechanism of Modulation of Cardiac Force by Temperature.

Morotti I, Marcello M, Sautariello G, Pertici I, Bianco P, Piazzesi G Int J Mol Sci. 2025; 26(2).

PMID: 39859186 PMC: 11764908. DOI: 10.3390/ijms26020469.

A FRET assay to quantitate levels of the human β-cardiac myosin interacting heads motif based on its near-atomic resolution structure.

Goluguri R, Guhathakurta P, Nandwani N, Dawood A, Yakota S, Roopnarine O bioRxiv. 2024; .

PMID: 39713291 PMC: 11661104. DOI: 10.1101/2024.12.05.626936.

Increased cardiac myosin super-relaxation as an energy saving mechanism in hibernating grizzly bears.

Van der Pijl R, Ma W, Lewis C, Haar L, Buhl A, Farman G Mol Metab. 2024; 92:102084.

PMID: 39694092 PMC: 11732570. DOI: 10.1016/j.molmet.2024.102084.

An integrated picture of the structural pathways controlling the heart performance.

Morotti I, Caremani M, Marcello M, Pertici I, Squarci C, Bianco P Proc Natl Acad Sci U S A. 2024; 121(50):e2410893121.

PMID: 39630866 PMC: 11648670. DOI: 10.1073/pnas.2410893121.

References

Bottinelli R, Reggiani C . Human skeletal muscle fibres: molecular and functional diversity. Prog Biophys Mol Biol. 2000; 73(2-4):195-262. DOI: 10.1016/s0079-6107(00)00006-7. View

Stehle R, Iorga B . Kinetics of cardiac sarcomeric processes and rate-limiting steps in contraction and relaxation. J Mol Cell Cardiol. 2010; 48(5):843-50. DOI: 10.1016/j.yjmcc.2009.12.020. View

Kawana M, Spudich J, Ruppel K . Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies. Front Physiol. 2022; 13:975076. PMC: 9548533. DOI: 10.3389/fphys.2022.975076. View

Keyt L, Duran J, Bui Q, Chen C, Miyamoto M, Silva Enciso J . Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics. Front Cardiovasc Med. 2022; 9:972301. PMC: 9489950. DOI: 10.3389/fcvm.2022.972301. View

Lehman S, Crocini C, Leinwand L . Targeting the sarcomere in inherited cardiomyopathies. Nat Rev Cardiol. 2022; 19(6):353-363. PMC: 9119933. DOI: 10.1038/s41569-022-00682-0. View

Nag S, Gollapudi S, Del Rio C, Spudich J, McDowell R . Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients. Sci Adv. 2023; 9(30):eabo7622. DOI: 10.1126/sciadv.abo7622. View

Walklate J, Ferrantini C, Johnson C, Tesi C, Poggesi C, Geeves M . Alpha and beta myosin isoforms and human atrial and ventricular contraction. Cell Mol Life Sci. 2021; 78(23):7309-7337. PMC: 8629898. DOI: 10.1007/s00018-021-03971-y. View

SONNENBLICK E . Correlation of myocardial ultrastructure and function. Circulation. 1968; 38(1):29-44. DOI: 10.1161/01.cir.38.1.29. View

LeWinter M, Granzier H . Cardiac titin: a multifunctional giant. Circulation. 2010; 121(19):2137-45. PMC: 2905226. DOI: 10.1161/CIRCULATIONAHA.109.860171. View

10.

Buckberg G, Hoffman J, Coghlan H, Nanda N . Ventricular structure-function relations in health and disease: Part I. The normal heart. Eur J Cardiothorac Surg. 2014; 47(4):587-601. DOI: 10.1093/ejcts/ezu278. View

11.

Mirsky I . Left ventricular stresses in the intact human heart. Biophys J. 1969; 9(2):189-208. PMC: 1367427. DOI: 10.1016/S0006-3495(69)86379-4. View

12.

Chirinos J, Segers P, Rietzschel E, De Buyzere M, Raja M, Claessens T . Early and late systolic wall stress differentially relate to myocardial contraction and relaxation in middle-aged adults: the Asklepios study. Hypertension. 2013; 61(2):296-303. DOI: 10.1161/HYPERTENSIONAHA.111.00530. View

13.

Gu H, Li Y, Fok H, Simpson J, Kentish J, Shah A . Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic Dysfunction: A Manifestation of Impaired Shortening Deactivation That Links Systolic to Diastolic Dysfunction and Preserves Systolic.... Hypertension. 2017; 69(4):633-640. PMC: 5344180. DOI: 10.1161/HYPERTENSIONAHA.116.08545. View

14.

Brunello E, Fusi L, Ghisleni A, Park-Holohan S, Ovejero J, Narayanan T . Myosin filament-based regulation of the dynamics of contraction in heart muscle. Proc Natl Acad Sci U S A. 2020; 117(14):8177-8186. PMC: 7149498. DOI: 10.1073/pnas.1920632117. View

15.

SONNENBLICK E, Parmley W, Buccino R, SPANN Jr J . Maximum force development in cardiac muscle. Nature. 1968; 219(5158):1056-8. DOI: 10.1038/2191056a0. View

16.

Hodt A, Stugaard M, Hisdal J, Stranden E, Atar D, Steine K . Regional LV deformation in healthy individuals during isovolumetric contraction and ejection phases assessed by 2D speckle tracking echocardiography. Clin Physiol Funct Imaging. 2012; 32(5):372-9. DOI: 10.1111/j.1475-097X.2012.01139.x. View

17.

Rodriguez E, HUNTER W, Royce M, Leppo M, Douglas A, Weisman H . A method to reconstruct myocardial sarcomere lengths and orientations at transmural sites in beating canine hearts. Am J Physiol. 1992; 263(1 Pt 2):H293-306. DOI: 10.1152/ajpheart.1992.263.1.H293. View

18.

Kobirumaki-Shimozawa F, Oyama K, Shimozawa T, Mizuno A, Ohki T, Terui T . Nano-imaging of the beating mouse heart in vivo: Importance of sarcomere dynamics, as opposed to sarcomere length per se, in the regulation of cardiac function. J Gen Physiol. 2015; 147(1):53-62. PMC: 4692490. DOI: 10.1085/jgp.201511484. View

19.

Bers D . Cardiac excitation-contraction coupling. Nature. 2002; 415(6868):198-205. DOI: 10.1038/415198a. View

20.

Tobacman L . Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol. 1996; 58:447-81. DOI: 10.1146/annurev.ph.58.030196.002311. View